Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma. - Tan CR; Gordan L; Richter J; DiLeo R; Mewawalla P; Larson S; Davies F; Oveisi D; Gupta-Werner N; Medhekar R; Yin X; Cortoos A; et al. (Future oncology (London, England), 2026)